Hortense Bergès

431 total citations
7 papers, 362 citations indexed

About

Hortense Bergès is a scholar working on Genetics, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Hortense Bergès has authored 7 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 4 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Molecular Biology. Recurrent topics in Hortense Bergès's work include Estrogen and related hormone effects (5 papers), Menopause: Health Impacts and Treatments (4 papers) and Angiogenesis and VEGF in Cancer (2 papers). Hortense Bergès is often cited by papers focused on Estrogen and related hormone effects (5 papers), Menopause: Health Impacts and Treatments (4 papers) and Angiogenesis and VEGF in Cancer (2 papers). Hortense Bergès collaborates with scholars based in France and Germany. Hortense Bergès's co-authors include Pierre Gourdy, Jean‐François Arnal, Françoise Lenfant, Coralie Fontaine, Audrey Billon-Galés, Gilles Flouriot, Henrik Laurell, Céline E. Toutain, Andrée Krust and Pierre Chambon and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Hortense Bergès

7 papers receiving 362 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hortense Bergès France 7 206 113 100 83 67 7 362
Babak Dehghani United States 6 217 1.1× 105 0.9× 92 0.9× 173 2.1× 131 2.0× 8 490
Christopher Hillard United States 4 140 0.7× 122 1.1× 42 0.4× 41 0.5× 86 1.3× 8 384
Paul D. Goetsch United States 7 150 0.7× 244 2.2× 42 0.4× 49 0.6× 68 1.0× 8 485
Nick Giannoukakis United States 8 129 0.6× 146 1.3× 68 0.7× 55 0.7× 12 0.2× 14 362
Laure Maneix United States 12 86 0.4× 162 1.4× 28 0.3× 58 0.7× 37 0.6× 24 353
J. Koudy Williams United States 7 425 2.1× 143 1.3× 332 3.3× 21 0.3× 57 0.9× 8 587
Tuyen Hoang Norway 11 143 0.7× 228 2.0× 36 0.4× 26 0.3× 60 0.9× 22 412
Marie Rhee South Korea 11 77 0.4× 104 0.9× 93 0.9× 44 0.5× 39 0.6× 23 341
Meggan Valrance United States 8 133 0.6× 115 1.0× 24 0.2× 34 0.4× 69 1.0× 10 342
JoEllen Welsh United States 5 113 0.5× 111 1.0× 32 0.3× 35 0.4× 73 1.1× 6 343

Countries citing papers authored by Hortense Bergès

Since Specialization
Citations

This map shows the geographic impact of Hortense Bergès's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hortense Bergès with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hortense Bergès more than expected).

Fields of papers citing papers by Hortense Bergès

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hortense Bergès. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hortense Bergès. The network helps show where Hortense Bergès may publish in the future.

Co-authorship network of co-authors of Hortense Bergès

This figure shows the co-authorship network connecting the top 25 collaborators of Hortense Bergès. A scholar is included among the top collaborators of Hortense Bergès based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hortense Bergès. Hortense Bergès is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Fontaine, Coralie, Audrey Billon-Galés, Gilles Flouriot, et al.. (2013). Tamoxifen Elicits Atheroprotection through Estrogen Receptor α AF-1 But Does Not Accelerate Reendothelialization. American Journal Of Pathology. 183(1). 304–312. 24 indexed citations
2.
Fontaine, Coralie, Isabelle Raymond‐Letron, Gilles Flouriot, et al.. (2013). The AF-1 Activation Function of Estrogen Receptor α Is Necessary and Sufficient for Uterine Epithelial Cell Proliferation In Vivo. Endocrinology. 154(6). 2222–2233. 54 indexed citations
3.
Billon-Galés, Audrey, Andrée Krust, Coralie Fontaine, et al.. (2011). Activation function 2 (AF2) of estrogen receptor-α is required for the atheroprotective action of estradiol but not to accelerate endothelial healing. Proceedings of the National Academy of Sciences. 108(32). 13311–13316. 99 indexed citations
4.
Bourgeois, Elvire Anne, Anaïs Levescot, Séverine Diem, et al.. (2010). A natural protective function of invariant NKT cells in a mouse model of innate‐cell‐driven lung inflammation. European Journal of Immunology. 41(2). 299–305. 24 indexed citations
5.
Autefage, Hélène, Virginie Garcia, Hortense Bergès, et al.. (2009). Lysosomal Serine Protease CLN2 Regulates Tumor Necrosis Factor-α-mediated Apoptosis in a Bid-dependent Manner. Journal of Biological Chemistry. 284(17). 11507–11516. 18 indexed citations
6.
Billon-Galés, Audrey, Coralie Fontaine, Victorine Douin‐Echinard, et al.. (2009). Endothelial Estrogen Receptor-α Plays a Crucial Role in the Atheroprotective Action of 17β-Estradiol in Low-Density Lipoprotein Receptor–Deficient Mice. Circulation. 120(25). 2567–2576. 92 indexed citations
7.
Toutain, Céline E., L. Brouchet, Isabelle Raymond‐Letron, et al.. (2008). Prevention of Skin Flap Necrosis by Estradiol Involves Reperfusion of a Protected Vascular Network. Circulation Research. 104(2). 245–254. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026